|
||||
|
Issue 126, 5 February 2003
|
||||
|
Trust's big Wellcome for Mark
PROFESSOR Mark Walport is the new director of the
Wellcome Trust. He succeeds Dr Mike Dexter, who retires from the
Trust at the end of March following a five year term as
director. Currently Professor of Medicine and Head of the Division of
Medicine at Imperial College London, Professor Walport will take up
his position on 1 June. He has been at Hammersmith Hospital since 1985 as Head of the
Rheumatology Section in the Royal Postgraduate Medical School. He was appointed Head of the Division of Medicine at Imperial
College London in 1997. His clinical and research interests focus
on immunology and the genetics of rheumatic diseases. "I am absolutely delighted - the Wellcome Trust is a very
special organisation," he said. "Not only does it make huge contributions to biomedical research
in the UK and internationally, it also plays an important role in
supporting the medical humanities. "I am looking forward enormously to leading the Trust during the
coming years." Commenting on the appointment, Sir Dominic Cadbury, Chairman of
the Wellcome Trust, added: "Mike Dexter has made an invaluable
contribution to the Trust over the past five years and the
appointment of Mark Walport as his successor ensures that strong
and effective leadership of our affairs will be continued. "As a former Governor, his knowledge of Trust business combined
with a proven track-record in science and management makes him the
ideal candidate to take on the challenges which face such a large
and diverse organisation." Professor Walport won the Roche Rheumatology Prize in 1991 and
the Graham Bull Prize in Clinical Science (Royal College of
Physicians) in 1996. |
||||
|
||||
| ©2003 Imperial College London |
||||